Heart & Lung: The Journal of Acute and Critical Care
Volume 38, Issue 3 , Pages 176-181, May 2009

Serum chlamydial lipopolysaccharide as a prognostic factor for a new cardiovascular event

  • Erkki Pesonen, MD, PhD

      Affiliations

    • Pediatric Cardiology, University Hospital of Lund, Sweden
    • Corresponding Author InformationCorresponding author: Erkki Pesonen, MD, PhD, Department of Pediatrics, Lund University Hospital, Getingevägen 4, SE-221 85 Lund, Sweden
  • ,
  • Terttu Tiirola, PhD

      Affiliations

    • National Public Health Institute, Oulu and Helsinki, Finland
  • ,
  • Eeva Andsberg, BM

      Affiliations

    • Pediatric Cardiology, University Hospital of Lund, Sweden
  • ,
  • Matti Jauhiainen, PhD

      Affiliations

    • National Public Health Institute, Oulu and Helsinki, Finland
  • ,
  • Matti Paldanius, MD, PhD

      Affiliations

    • National Public Health Institute, Oulu and Helsinki, Finland
  • ,
  • Kenneth Persson, MD, PhD

      Affiliations

    • Medical Microbiology, University Hospital of Malmö, Sweden
  • ,
  • Pekka Saikku, MD, PhD

      Affiliations

    • Department of Medical Microbiology, University of Oulu, Finland
  • ,
  • Seppo Sarna, D Soc Sc

      Affiliations

    • Department of Public Health, University of Helsinki, Finland
  • ,
  • Hans Öhlin, MD, PhD

      Affiliations

    • Cardiology, University Hospital of Lund, Sweden
  • ,
  • Maija Leinonen, PhD

      Affiliations

    • National Public Health Institute, Oulu and Helsinki, Finland

published online 06 October 2008.

Background

Infections caused by Chlamydia pneumoniae are considered to participate in inflammatory processes leading to coronary artery disease. After a primary infection, the bacteria remain dormant intracellularly causing a chronic inflammatory stimulus.

Materials and Methods

Blood samples were obtained from 235 patients with acute myocardial infarction (AMI) and 108 patients with unstable angina pectoris (UA). We evaluated the prognostic significance of bacterial and viral antibody titers, serum troponin T, C-reactive protein, and chlamydial lipopolysaccharide (cLPS) concentrations during acute coronary syndrome of patients with AMI and UA for cardiovascular death and new UA and AMI that required hospital care during a 6-year follow-up.

Results

Serum cLPS levels correlated with C-reactive protein and serum troponin T concentrations during acute coronary events. Patients with AMI had significantly higher serum concentration of cLPS compared with patients with UA. Enterovirus antibody titers and cholesterol-lowering therapy at admission of the index event were negatively correlated with cLPS concentration (r = −.198, P = .0003 and r = −.26, P = .019, respectively). The presence of circulating cLPS was associated with a hazard ratio of 2.04 for a new cardiovascular event during the follow-up period (P = .006). The area under the curve in the receiver operating graph was .572.

Conclusion

cLPS is evidently liberated from the infected atherosclerotic tissue during an acute coronary event. Our study supports the view that inflammation caused by C. pneumoniae infection is an important but as yet poorly understood factor in the development of atherosclerosis and may play a role in acute vascular events.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 12.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 The study was supported by grants from Lund University, Lund University Hospital, Academy of Finland, and Finnish Funding Agency for Technology and Innovation.

PII: S0147-9563(08)00120-9

doi:10.1016/j.hrtlng.2008.06.001

Heart & Lung: The Journal of Acute and Critical Care
Volume 38, Issue 3 , Pages 176-181, May 2009